Blueprint Medicines Corp (BPMC)
94.15
-2.47
(-2.56%)
USD |
NASDAQ |
Nov 22, 16:00
94.20
+0.05
(+0.05%)
After-Hours: 20:00
Blueprint Medicines Market Cap: 5.981B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 5.981B |
| November 21, 2024 | 6.138B |
| November 20, 2024 | 6.023B |
| November 19, 2024 | 6.010B |
| November 18, 2024 | 5.729B |
| November 15, 2024 | 5.634B |
| November 14, 2024 | 6.076B |
| November 13, 2024 | 6.154B |
| November 12, 2024 | 6.138B |
| November 11, 2024 | 6.344B |
| November 08, 2024 | 6.405B |
| November 07, 2024 | 6.441B |
| November 06, 2024 | 6.329B |
| November 05, 2024 | 6.197B |
| November 04, 2024 | 5.837B |
| November 01, 2024 | 5.762B |
| October 31, 2024 | 5.559B |
| October 30, 2024 | 5.669B |
| October 29, 2024 | 5.298B |
| October 28, 2024 | 5.258B |
| October 25, 2024 | 5.233B |
| October 24, 2024 | 5.272B |
| October 23, 2024 | 5.356B |
| October 22, 2024 | 5.487B |
| October 21, 2024 | 5.432B |
| Date | Value |
|---|---|
| October 18, 2024 | 5.457B |
| October 17, 2024 | 5.457B |
| October 16, 2024 | 5.668B |
| October 15, 2024 | 5.659B |
| October 14, 2024 | 5.625B |
| October 11, 2024 | 5.635B |
| October 10, 2024 | 5.519B |
| October 09, 2024 | 5.557B |
| October 08, 2024 | 5.551B |
| October 07, 2024 | 5.668B |
| October 04, 2024 | 5.623B |
| October 03, 2024 | 5.588B |
| October 02, 2024 | 5.759B |
| October 01, 2024 | 5.711B |
| September 30, 2024 | 5.870B |
| September 27, 2024 | 5.863B |
| September 26, 2024 | 5.642B |
| September 25, 2024 | 5.511B |
| September 24, 2024 | 5.718B |
| September 23, 2024 | 5.705B |
| September 20, 2024 | 5.808B |
| September 19, 2024 | 5.761B |
| September 18, 2024 | 5.659B |
| September 17, 2024 | 5.480B |
| September 16, 2024 | 5.467B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.278B
Minimum
Feb 24 2023
7.611B
Maximum
Jul 16 2024
4.520B
Average
4.270B
Median
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.25B |
| Regeneron Pharmaceuticals Inc | 81.10B |
| NovaBay Pharmaceuticals Inc | 3.327M |
| Palatin Technologies Inc | 18.77M |
| iBio Inc | 24.15M |
Market Cap Related Metrics
| PS Ratio | 13.60 |
| Price to Book Value | 19.10 |
| Price | 94.15 |
| Earnings Yield | -2.24% |